Truist Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $34.4M | Sell |
272,022
-3,844
| -1% | -$506K | 0.04% | 323 |
|
|
2026
Q1 | $38.4M | Sell |
275,866
-34,074
| -11% | -$4.77M | 0.05% | 286 |
|
|
2025
Q4 | $38M | Sell |
309,940
-397
| -0.1% | -$48.2K | 0.05% | 282 |
|
|
2025
Q3 | $34.4M | Sell |
310,337
-42,786
| -12% | -$4.86M | 0.05% | 298 |
|
|
2025
Q2 | $39.2M | Sell |
353,123
-7,052
| -2% | -$751K | 0.06% | 273 |
|
|
2025
Q1 | $40.4M | Sell |
360,175
-9,560
| -3% | -$986K | 0.06% | 254 |
|
|
2024
Q4 | $34.2M | Sell |
369,735
-17,375
| -4% | -$1.56M | 0.05% | 289 |
|
|
2024
Q3 | $32.5M | Sell |
387,110
-19,791
| -5% | -$1.51M | 0.05% | 300 |
|
|
2024
Q2 | $27.9M | Sell |
406,901
-39,572
| -9% | -$2.64M | 0.04% | 336 |
|
|
2024
Q1 | $32.7M | Sell |
446,473
-47,044
| -10% | -$3.62M | 0.05% | 314 |
|
|
2023
Q4 | $40M | Sell |
493,517
-79,928
| -14% | -$6.22M | 0.06% | 266 |
|
|
2023
Q3 | $43M | Buy |
573,445
+7,890
| +1% | +$607K | 0.07% | 245 |
|
|
2023
Q2 | $43.6M | Sell |
565,555
-95,273
| -14% | -$7.6M | 0.07% | 241 |
|
|
2023
Q1 | $54.8M | Sell |
660,828
-162,731
| -20% | -$13.5M | 0.09% | 200 |
|
|
2022
Q4 | $70.7M | Sell |
823,559
-98,617
| -11% | -$7.81M | 0.12% | 167 |
|
|
2022
Q3 | $56.9M | Buy |
922,176
+145,515
| +19% | +$9.18M | 0.11% | 187 |
|
|
2022
Q2 | $48M | Buy |
776,661
+78,158
| +11% | +$4.84M | 0.09% | 210 |
|
|
2022
Q1 | $41.5M | Sell |
698,503
-25,743
| -4% | -$1.65M | 0.07% | 265 |
|
|
2021
Q4 | $52.6M | Buy |
724,246
+3,034
| +0.4% | +$209K | 0.08% | 237 |
|
|
2021
Q3 | $50.4M | Sell |
721,212
-355,713
| -33% | -$25M | 0.08% | 230 |
|
|
2021
Q2 | $74.2M | Sell |
1,076,925
-22,152
| -2% | -$1.48M | 0.12% | 178 |
|
|
2021
Q1 | $71M | Buy |
1,099,077
+62,826
| +6% | +$4.05M | 0.12% | 182 |
|
|
2020
Q4 | $60.4M | Sell |
1,036,251
-53,068
| -5% | -$3.2M | 0.12% | 186 |
|
|
2020
Q3 | $68.8M | Buy |
1,089,319
+136,708
| +14% | +$9.48M | 0.15% | 153 |
|
|
2020
Q2 | $73.3M | Sell |
952,611
-273,784
| -22% | -$21M | 0.16% | 144 |
|
|
2020
Q1 | $91.7M | Sell |
1,226,395
-262,916
| -18% | -$18.2M | 0.24% | 99 |
|
|
2019
Q4 | $96.8M | Buy |
1,489,311
+1,357,504
| +1,030% | +$88.4M | 0.2% | 116 |
|
|
2019
Q3 | $8.35M | Buy |
131,807
+8,817
| +7% | +$576K | 0.14% | 160 |
|
|
2019
Q2 | $8.31M | Sell |
122,990
-3,164
| -3% | -$208K | 0.14% | 160 |
|
|
2019
Q1 | $8.2M | Buy |
126,154
+736
| +0.6% | +$48.9K | 0.15% | 149 |
|
|
2018
Q4 | $7.84M | Sell |
125,418
-82,147
| -40% | -$5.74M | 0.16% | 144 |
|
|
2018
Q3 | $16M | Sell |
207,565
-15,241
| -7% | -$1.15M | 0.29% | 92 |
|
|
2018
Q2 | $15.8M | Sell |
222,806
-5,021
| -2% | -$355K | 0.3% | 89 |
|
|
2018
Q1 | $17.2M | Sell |
227,827
-7,833
| -3% | -$623K | 0.33% | 79 |
|
|
2017
Q4 | $16.9M | Sell |
235,660
-19,479
| -8% | -$1.48M | 0.32% | 81 |
|
|
2017
Q3 | $20.7M | Sell |
255,139
-26,891
| -10% | -$2.06M | 0.4% | 63 |
|
|
2017
Q2 | $20M | Sell |
282,030
-4,099
| -1% | -$273K | 0.4% | 65 |
|
|
2017
Q1 | $19.4M | Buy |
286,129
+3,232
| +1% | +$227K | 0.39% | 69 |
|
|
2016
Q4 | $20.3M | Buy |
282,897
+1,107
| +0.4% | +$82.3K | 0.41% | 58 |
|
|
2016
Q3 | $22.3M | Buy |
281,790
+1,026
| +0.4% | +$83.3K | 0.46% | 53 |
|
|
2016
Q2 | $23.4M | Buy |
280,764
+139,781
| +99% | +$12.4M | 0.49% | 45 |
|
|
2016
Q1 | $13M | Buy |
140,983
+20,122
| +17% | +$1.81M | 0.34% | 78 |
|
|
2015
Q4 | $12.2M | Sell |
120,861
-12,639
| -9% | -$1.32M | 0.32% | 83 |
|
|
2015
Q3 | $13.1M | Sell |
133,500
-14,912
| -10% | -$1.66M | 0.34% | 83 |
|
|
2015
Q2 | $17.4M | Sell |
148,412
-12,962
| -8% | -$1.42M | 0.47% | 53 |
|
|
2015
Q1 | $15.8M | Sell |
161,374
-15,678
| -9% | -$1.59M | 0.45% | 61 |
|
|
2014
Q4 | $16.7M | Sell |
177,052
-12,073
| -6% | -$1.25M | 0.49% | 56 |
|
|
2014
Q3 | $20.1M | Sell |
189,125
-13,789
| -7% | -$1.35M | 0.61% | 39 |
|
|
2014
Q2 | $16.8M | Sell |
202,914
-7,522
| -4% | -$585K | 0.5% | 53 |
|
|
2014
Q1 | $14.9M | Buy |
210,436
+2,006
| +1% | +$157K | 0.47% | 57 |
|
|
2013
Q4 | $15.7M | Sell |
208,430
-438
| -0.2% | -$30.5K | 0.5% | 52 |
|
|
2013
Q3 | $13.1M | Buy |
208,868
+6,445
| +3% | +$385K | 0.47% | 55 |
|
|
2013
Q2 | $10.4M | Buy |
+202,423
| New | +$10.6M | 0.39% | 67 |
|
Other funds holding GILD
Truist Financial's GILD Position: Q2 2026 in Review
Truist Financial reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $506K and leaving 272,022 shares worth $34.4M. The position accounts for 0.04% of the portfolio, ranked #323.
Truist Financial first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $96.8M in Q4 2019. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Truist Financial held 272,022 shares of Gilead Sciences worth $34.4M as of Q2 2026.
- Truist Financial sold 3,844 Gilead Sciences shares in Q2 2026, an estimated $506K.
- Gilead Sciences made up 0.04% of Truist Financial's portfolio in Q2 2026, its #323 holding.
- Truist Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Truist Financial's Gilead Sciences position peaked at $96.8M in Q4 2019.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.